| 1 |
32768575 | Effect of NMO-IgG on the interleukin-6 cascade in astrocytes via activation of the JAK/STAT3 signaling pathway. | 2020 Oct 1 |
1 |
| 2 |
28039266 | Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells. | 2017 Jun 15 |
2 |
| 3 |
28960447 | JAK1/2 Inhibitors AZD1480 and CYT387 Inhibit Canine B-Cell Lymphoma Growth by Increasing Apoptosis and Disrupting Cell Proliferation. | 2017 Nov |
1 |
| 4 |
25504635 | Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia. | 2015 Feb |
1 |
| 5 |
25810010 | JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth. | 2015 Mar |
1 |
| 6 |
25131802 | Initial solid tumor testing (stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing program. | 2014 Nov |
3 |
| 7 |
25193869 | JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis. | 2014 Nov 6 |
1 |
| 8 |
23847256 | AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors. | 2013 |
1 |
| 9 |
24158701 | The Janus kinases inhibitor AZD1480 attenuates growth of small cell lung cancers in vitro and in vivo. | 2013 Dec 15 |
1 |
| 10 |
23056499 | AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines. | 2012 |
1 |
| 11 |
22027691 | Therapeutic potential of AZD1480 for the treatment of human glioblastoma. | 2011 Dec |
1 |